Macrocyclic peptidomimetic protease inhibitor and use thereof
US-2024327458-A1 · Oct 3, 2024 · US
US11970501B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11970501-B2 |
| Application number | US-202117464598-A |
| Country | US |
| Kind code | B2 |
| Filing date | Sep 1, 2021 |
| Priority date | Sep 2, 2020 |
| Publication date | Apr 30, 2024 |
| Grant date | Apr 30, 2024 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention relates to highly polarizable 3D organic perovskites of the general formula ABX 3 , prepared by introducing halogen functional groups in the A-site cation (in which the A and B sites are occupied by organic cations and the X site is a monovalent non-metallic counterion). The (DCl)(NH 4 )(BF 4 ) 3 crystal exhibits a strong linear electrooptic (EO) effect with an effective EO coefficient of 20 pmV −1 , which is 10 times higher than that of metal halide perovskites. These 3D organic perovskites are solution processed and compatible with silicon, and illustrate the potential of rationally-designed all-organic perovskites for use in on-chip modulators, electro-optic devices, piezoelectric devices, or silicon photonics devices.
Opening claim text (preview).
What is claimed is: 1. A 3D organic perovskite having the Formula (I): ABX 3 (I) wherein: A has the formula DR 2+ , wherein DR 2+ is: wherein R is F, Cl, Br, CN, or OH; and R′ is H or CH 3 ; B is NH 4 + ; and X is BF 4 − or PF 6 − . 2. The organic perovskite of claim 1 , wherein R is F or Cl. 3. The organic perovskite of claim 1 or 2 , wherein X is BF 4 − . 4. The organic perovskite of claim 1 , which is (DCI)(NH 4 )(BF 4 ) 3 . 5. The organic perovskite of claim 1 , which is (DF)(NH 4 )(BF 4 ) 3 .
Bridged systems · CPC title
Coordination compounds · CPC title
based on electro-optical organic material (G02F1/07, {G02F1/13} take precedence) · CPC title
Halides or oxyhalides of phosphorus · CPC title
Boron halogen compounds · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.